Antimicrobial Stewardship

The CDC announced $22 million in awards and the launch of two programs that will focus on preventing and combating antimicrobial-resistant infections.

WASHINGTON – In this video, Cornelius (Neil) J. Clancy, MD, discusses a presentation he gave at the World Anti-Microbial Resistance Congress on antimicrobial use, stewardship and resistance during the COVID-19 pandemic.

WASHINGTON — Infectious Diseases Society of America President Daniel P. McQuillen, MD, FIDSA, delivered a presentation at the World Anti-Microbial Resistance Congress on issues related to antimicrobial stewardship and the ID workforce.

Fluoroquinolone use decreased between 2015 and 2016 due in part to FDA advisories. However, their use still varies significantly based on provider age and other characteristics, according to a study.

The Infectious Diseases Society of America said it was “encouraged” by a Biden administration plan to allocate more than $2 billion in federal funding to build infrastructure to combat drug-resistant infections.

Antimicrobial stewardship has been defined as coordinated interventions designed to improve and measure appropriate use of antimicrobial agents by promoting the selection of optimal drug regimens.

Data from Veterans Health Administration pharmacies showed that outpatient antibiotic prescriptions declined by almost 4% annually from 2011 to 2018, researchers reported at the ECCMID virtual meeting.

An intervention researchers hoped would improve infection management did not significantly reduce antimicrobial use among nursing home residents with dementia, data showed.

The American Society of Microbiology (ASM) and Federation of European Microbiological Societies (FEMS) collaborated to launch a joint meeting this year called the World Microbe Forum, which combined ASM Microbe and FEMS Congress 2021.

The results of a randomized controlled trial demonstrated that a 6-week course of antibiotics for prosthetic joint infection was not noninferior to a 12-week course and resulted in a higher percentage of patients with unfavorable outcomes.